GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 65 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q4 2023. The put-call ratio across all filers is 2.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $395 | +194.8% | 39,300 | -15.7% | 0.00% | – |
| Q3 2023 | $134 | -28.3% | 46,600 | -5.1% | 0.00% | – |
| Q2 2023 | $187 | +105.5% | 49,100 | +0.4% | 0.00% | – |
| Q1 2023 | $91 | -19.5% | 48,900 | -0.2% | 0.00% | – |
| Q4 2022 | $113 | -99.9% | 49,000 | -2.6% | 0.00% | – |
| Q3 2022 | $162,000 | -40.9% | 50,300 | +0.8% | 0.00% | – |
| Q2 2022 | $274,000 | +398.2% | 49,900 | +111.4% | 0.00% | – |
| Q1 2022 | $55,000 | – | 23,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 3,111,551 | $17,114,000 | 1.62% |
| Paradigm Biocapital Advisors LP | 783,445 | $4,309,000 | 0.86% |
| Orbimed Advisors | 7,884,870 | $43,367,000 | 0.79% |
| Vivo Capital, LLC | 961,359 | $5,287,000 | 0.53% |
| EcoR1 Capital, LLC | 1,921,310 | $10,567,000 | 0.36% |
| Temasek Holdings (Private) Ltd | 9,901,940 | $54,460,670 | 0.30% |
| Capital International, Inc./CA/ | 2,993,695 | $16,465,000 | 0.23% |
| Capital International Sarl | 302,182 | $1,662,000 | 0.13% |
| FEDERATED HERMES, INC. | 1,298,578 | $7,142,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 257,924 | $1,419,000 | 0.01% |